Effects of enriched seafood sticks (heat-inactivated B. animalis subsp. lactis CECT 8145, inulin, omega-3) on cardiometabolic risk factors and gut microbiota in abdominally obese subjects: randomized controlled trial
Open Access
- 28 May 2022
- journal article
- research article
- Published by Springer Nature in European Journal of Nutrition
- Vol. 61 (7) , 3597-3611
Abstract
Purpose: To assess the effects of enriched seafood sticks with postbiotic and bioactive compounds on CMD risk factors and the gut microbiota in abdominally obese individuals. Methods: Randomized, double-blind, parallel, placebo-controlled trial with abdominally obese individuals. Participants (n = 120) consumed 50 g/day of enriched seafood sticks containing SIAP: (1010 colony forming units (CFUs) of heat-inactivated B. animalis subsp. lactis CECT8145, 370 mg/day omega 3 and 1.7 g/day inulin), or 50 g/day of placebo seafood sticks for 12 weeks. At 12 weeks, an acute single-dose study of 4 h was performed. Results: Sustained SIAP2 consumption significantly decreased the insulin by − 5.25 mg/dL and HOMA-IR (homeostatic Model Assessment of Insulin Resistance) by − 1.33. In women, SIAP2 consumption significantly decreased the pulse pressure (PP) by − 4.69 mmHg. Gut microbiota analysis showed a negative association between glycemic parameter reduction and Alistipes finegoldii and Ruminococcaceae, and between PP reduction and Prevotella 9-ASV0283 and Christensenellaceae. In the acute single dose-study 4-h, SIAP2 consumption produced a lower increase in the postprandial circulating triglyceride levels [23.9 (7.03) mg/dL (mean [standard error])] than the observed with placebo [49.0 (9.52)] mg/dL. Conclusion: In abdominally obese individuals, enriched seafood sticks induce a potential protection against type 2 diabetes development by the reduction in the insulin and HOMA-IR; and in cardiovascular disease, in women, by the PP reduction. These effects are accompanied by partial changes in the gut microbiota composition. The enriched seafood sticks reduce the atherogenic triglyceride postprandial concentrations. Our results support the use of enriched seafood sticks as a complementary strategy in the management of CMD risk factors. Registration number of Clinical Trial: (www.ClinicalTrials.gov): NCT03630588 (August 15, 2018).Keywords
Funding Information
- Centre for Industrial Technological Development (CER-20191010)
- Universitat Rovira i Virgili
This publication has 49 references indexed in Scilit:
- Dietary intervention impact on gut microbial gene richnessNature, 2013
- TAp63γ Demethylation Regulates Protein Stability and Cellular Distribution during Neural Stem Cell DifferentiationPLOS ONE, 2012
- The SILVA ribosomal RNA gene database project: improved data processing and web-based toolsNucleic Acids Research, 2012
- Cocoa, Hazelnuts, Sterols and Soluble Fiber Cream Reduces Lipids and Inflammation Biomarkers in Hypertensive Patients: A Randomized Controlled TrialPLOS ONE, 2012
- Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitusLipids in Health and Disease, 2012
- Waist circumference and mortality: Impact of associated risk factorsDiabetes & Metabolism, 2011
- Quality control and preprocessing of metagenomic datasetsBioinformatics, 2011
- Acute Effects of High-Fat Meals Enriched With Walnuts or Olive Oil on Postprandial Endothelial FunctionJACC, 2006
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Abdominal diameters as indicators of visceral fat: comparison between magnetic resonance imaging and anthropometryBritish Journal of Nutrition, 1993